- Obama’s regulatory agenda will cost U.S. economy $143B next year: report
- Patriot Act author on James Clapper: Fire, prosecute him
- Russia P.M. Medvedev: No amnesty for political prisoners
- Michigan GOP Senate hopeful reminds government is the ‘servant’
- Christmas, by Congress: Members mull a 15-cent tax on trees
- U.S. unemployment falls to five-year low of 7 percent; 203K jobs added
- World mourns Nelson Mandela and celebrates his life; burial set for Dec. 15
- Bill O’Reilly reminds: Nelson Mandela ‘was a communist’
- John Boehner says GOP should support gay candidates: ‘I do’
- Grass-Whopper: Pan-fried cricket burgers go over big in New York City
Walgreens pays record $80 million settlement for improper drug sales
Question of the Day
Walgreens Corp., the nation’s largest drugstore chain, agreed Tuesday to pay $80 million in civil penalties to resolve accusations of negligently letting controlled substances such as oxycodone and other prescription pain killers be diverted for abuse and black-market sales.
Mark R. Trouville, the special agent in charge of the U.S. Drug Enforcement Administration’s Miami field division, said the agreement settles administrative actions and civil penalties regarding Walgreens‘ Jupiter, Fla., distribution center and six Walgreens retail pharmacies, along with similar open civil investigations in Colorado, Michigan and New York.
The settlement, the largest in DEA history, resolves charges that the company committed an unprecedented number of record-keeping and dispensing violations. The Walgreens distribution center in Jupiter was the largest supplier of oxycodone to retail pharmacies in Florida.
“National pharmaceutical chains are not exempt from following the law. This settlement sends out a clear message that all DEA registrants will be held accountable when they violate the law and threaten public health and safety,” Mr. Trouville said. “The DEA will continue its efforts to work with our registrants and our law enforcement partners to combat pharmaceutical drug abuse and diversion in Florida.”
The settlement agreement covers accusations that the Jupiter distribution center failed to comply with regulations that required it to report to the DEA suspicious prescription drug orders it received from Walgreens‘ retail pharmacies. Walgreens‘ purported failure to sufficiently report suspicious orders was a systematic practice that resulted in at least tens of thousands of violations and allowed Walgreens‘ retail pharmacies to order and receive at least three times the Florida average for drugs such as oxycodone.
Mr. Trouville also said the six retail pharmacies in Florida that received the suspicious drug shipments from the Jupiter distribution center filled customer prescriptions that they knew or should have known were not for legitimate medical use. In addition, he said, these retail pharmacies and others in the U.S. failed to properly identify and mark, as required by DEA regulations, hard-copy controlled-substance prescriptions that were outsourced to a “central fill” pharmacy for filling.
Without Walgreens‘ retail pharmacies identifying these outsourced prescriptions, the DEA could not accurately determine which prescriptions were filled from the retail pharmacies’ own drug supplies and which were filled by a “central fill.” Consequently, the DEA could not determine the accuracy of the retail pharmacies’ drug records.
In addition to the $80 million civil penalties, Mr. Trouville said, the settlement revokes the company’s ability to distribute or dispense controlled substances for two years, ending in 2014. As part of the settlement, Walgreens admitted that it failed to uphold its obligations as a DEA registrant regarding the above-described conduct. Furthermore, Walgreens has agreed to create a Department of Pharmaceutical Integrity to ensure regulatory compliance and prevent the diversion of controlled substances.
Mr. Trouville also said Walgreens agreed to enhance its training and compliance programs, and to no longer monetarily or otherwise compensate its pharmacists based on the volume of prescriptions filled.
© Copyright 2013 The Washington Times, LLC. Click here for reprint permission.
About the Author
Jerry Seper is the investigative editor for The Washington Times.
- With bombs away, drug traffickers and illegal immigrants make their play
- Medical-device company exec admits to bilking shareholders of $400M
- Justice Dept: Florida's disabled children unnecessarily put in nursing facilities
- Man gets 11 years in Philadelphia mob crackdown
- Eric Holder asks for respect from protesters of George Zimmerman verdict
Latest Blog Entries
- Spike in battlefield deaths linked to restrictive rules of engagement
- Bill OReilly reminds: Nelson Mandela was a communist
- U.S. pilot scares off Iranians with 'Top Gun'-worthy stunt: 'You really ought to go home'
- Hack attack: 2 million Facebook, Twitter passwords stolen
- Kill team: Obama war chiefs widen drone death zones
- Obama administration issues permits for wind farms to kill more eagles
- Embryonic stem cell research falls out of favor as scientists go ethical
- EDITORIAL: Our ideological president
- PRUDEN: British press horrified as London's new mayor dares to proclaim the truth
- MILLER: Obamacare enrollees include 101 members of the House of Representatives
Independent voices from the The Washington Times Communities
The Constitution: Every issue, every time. No exceptions, no excuses. And how to get from here to there.
Why can’t humans just be free to be humans?
Get in the middle of all the action inside and outside the boxing ring.
Find the latest news and happening that effect those in the Washington D.C., Northern Virginia and Maryland Metro region.
White House pets gone wild!